Marianne Abouyared

Dr. Marianne Abouyared

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MAMarianne Abouyared
Marianne Abouyared
AKAndrew P. Katz
Andrew P. Katz
LELiliana Ein
Liliana Ein
JKJill Ketner
Jill Ketner
ZSZoukaa Sargi
Zoukaa Sargi
JLJason M. Leibowitz
Jason M. Leibowitz

25 November 2024 in Head & Neck
Verified
Journal Article
Open access
JGJames C Gates
James C Gates
MAMarianne Abouyared
Marianne Abouyared
YSYelizaveta Shnayder
Yelizaveta Shnayder
DFD. Gregory Farwell
D. Gregory Farwell
ADAndrew Day
Andrew Day
JEJoel Epstein
Joel Epstein
Background: Oral potentially malignant disorders (OPMDs) occur in up to 4%–5% of the population, of which oral leukoplakia (OL) is the most common subtype. Predicting high‐risk OL remains a challenge. Early diagnosis and effective treatment are thought to be of paramount importance to improve outcomes.Methods: We searched PubMed and Clinicaltrials.gov data for updates in the clinical management of OL from 2015 to current.Results: Recent publication of large cohorts of patients with OL aids in counseling patients regarding risk of malignant transformation. Management for OL includes surveillance, excision, and laser surgery, as well as local and systemic approaches to chemoprevention. Several new entities show promise regarding candidate biomarkers, chemoprevention agents, and diagnostic adjuncts, though all require further validation.Conclusion: This update serves to further inform clinical management of OL and provide impetus for future investigations.Trial Registration: NCT00099021, NCT00951379, NCT05727761, NCT05727761

9 March 2023 in Head & Neck
Verified
Journal Article
Open access
PDF file
KYKurtis Young
Kurtis Young
HBHannah Bulosan Bs
Hannah Bulosan Bs
CKCarley C. Kida
Carley C. Kida
ABArnaud F. Bewley
Arnaud F. Bewley
MAMarianne Abouyared
Marianne Abouyared
ABAndrew Birkeland
Andrew Birkeland
There are limited data supporting the commonly suggested 5 mm margin cutoff as the optimum value in defining clear margins in oral cancer. A database search of Pubmed/Medline, Web of Science, and EBSCOhost was performed from inception to June 2022. A random‐effects model was chosen for this meta‐analysis. The Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) guidelines were followed throughout this study. Seven studies met study criteria (2215 patients). The risk ratio was significantly higher for margins <5 mm when compared to those ≥5 mm (2.09 (95%CI: 1.53–2.86, I2 = 0.47)). Subgroup analysis (I2 = 0.15) of margin distances of 0.0–0.9, 1.0–1.9, 2.0–2.9, 3.0–3.9, and 4.0–4.9 mm calculated risk ratios for local recurrence of 2.96, 2.01, 2.17, 1.8, and 0.98, respectively. Margins between 4.0 and 4.9 mm had similar risk ratios for local recurrence compared to ≥5 mm, while margins <4.0 were significantly higher.

2 October 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CFChristopher Fundakowski
Christopher Fundakowski
JCJohnathan Castaño
Johnathan Castaño
MAMarianne Abouyared
Marianne Abouyared
KLKaming Lo
Kaming Lo
ARAndrew Rivera
Andrew Rivera
ZSZoukaa Sargi
Zoukaa Sargi

4 April 2014 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
JLJason M. Leibowitz
Jason M. Leibowitz
CFChristopher E. Fundakowski
Christopher E. Fundakowski
MAMarianne Abouyared
Marianne Abouyared
ARAndrew Rivera
Andrew Rivera
JRJason Rudman
Jason Rudman
FCFrancisco Civantos
Francisco Civantos